Edap Tms SA
NASDAQ:EDAP
Relative Value
The Relative Value of one
EDAP
stock under the Base Case scenario is
4.24
USD.
Compared to the current market price of 4.25 USD,
Edap Tms SA
is
Fairly Valued.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
EDAP Competitors Multiples
Edap Tms SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Edap Tms SA
NASDAQ:EDAP
|
158.9m USD | 2.1 | -6.9 | -6.4 | -6.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
196.4B USD | 4.3 | 29.5 | 16.9 | 23.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
177.6B USD | 17.4 | 61.2 | 46.5 | 57.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
146.1B USD | 5.7 | 43.9 | 22.2 | 26.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
121.1B USD | 3.4 | 25.8 | 14.1 | 20.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.7B USD | 5.2 | 36.3 | 21.3 | 28.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.6B EUR | 2 | 21.7 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.1B USD | 11.5 | 46.9 | 33.3 | 36.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 8 | 45.4 | 25 | 27.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.8B USD | 2.2 | 27.2 | 10.6 | 17.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37.7B USD | 6.8 | 24.7 | 17.5 | 19.4 |